Efficacy of Silymarin for Acute Hepatitis

Summary

The overall objective of this project is to assess whether Silymarin therapy shortens illness or prevents complications in patients with acute hepatitis. We will specifically compare responses in acute hepatitis patients treated with Silymarin to those given a control preparation of a vitamin supplements in a double blinded, randomized, placebo-controlled trial.

Timeline

Start

2003-07

Primary completion

—

Completion

2005-10

Drugs

Indications